Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Proponents believe that having real money on the line, and a large crowd of investors, encourages a more accurate election forecast than polling data can provide. By Kaleigh Rogers Kaleigh Rogers ...

When Rose Levy Beranbaum’s “Cake Bible” was first published in 1988, it was as though the wheel had been re-invented. Sure, there were other books devoted to cakes (many of them excellent ...

experiences with all 3 of her children. Now she's trying to warn others about RSV. (Photo: Gabrielle Hopkins Photography/Courtesy of Shawn Johnson East) As a 2007 World Champion and 2008 Olympic ...

As winter's chill sweeps across the nation, health experts have urged Brits to brace for a 'tripledemic', with a likely uptick in cases of covid, flu, and RSV. Brits are urged to get vaccinated ...

The FDA has endorsed Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo for adults ages 18 to 59 who are at an increased risk of developing lower respiratory tract disease (LRTD).

Pfizer’s Abryso is designed to stimulate an immune response against RSV prefusion conformation (pre-F), thereby providing protection against lower respiratory tract disease caused by RSV. Image credit ...

The U.S. is entering the second RSV season in which vaccines for the virus are available for older adults. Yet, despite three options on the market from Pfizer, GSK and Moderna, uptake has been slow ...

Ottawa Public Health (OPH) is recommending that eligible residents at higher risk of severe illness protect themselves against respiratory syncytial virus (RSV) this respiratory illness season. RSV is ...

The vaccine, called Abrysvo, has been approved for the prevention of lower respiratory tract diseases, such as pneumonia and bronchitis, caused by respiratory syncytial virus, or RSV, in people ...